Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Intraocular Lymphoma × vandetanib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 10 Carcinoma, Medullary 9 Thyroid Neoplasms 7 Lung Neoplasms 6 Neoplasm Metastasis 5 Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Kidney Neoplasms 2 Gliosarcoma 2 Glioblastoma 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid cancer, medullary 1 Thyroid Diseases 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Precancerous Conditions 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Oligodendroglioma 1 Multiple Endocrine Neoplasia Type 2b 1 Multiple Endocrine Neoplasia Type 2a 1

Interventions

Rituximab 7 Peripheral Blood Stem Cell Transplantation 6 fludarabine phosphate 5 Whole-Body Irradiation 5 Cyclophosphamide 5 Etoposide 4 Cyclosporine 4 Tacrolimus 3 Mycophenolic Acid 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Carboplatin 3 Lenalidomide 2 Dexamethasone 2 Calcium Dobesilate 2 Busulfan 2 Antilymphocyte Serum 2 sodium thiosulfate 1 pegfilgrastim 1 oblimersen 1 merphos 1 etoposide phosphate 1 Vorinostat 1 Vincristine 1 Transplantation 1 Thiotepa 1 Therapeutics 1 Sirolimus 1 Radiotherapy 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡